Results 271 to 280 of about 36,244 (312)

Persistence of immune responses to the Sinopharm/BBIBP‐CorV vaccine

Immunity, Inflammation and Disease, 2022
AbstractBackgroundTo determine the kinetics and persistence of immune responses following the Sinopharm/BBIBP‐CorV, we investigated immune responses in a cohort of Sri Lankan individuals.MethodsSARS‐CoV‐2 specific total antibodies were measured in 20–39 years (n = 61), 40–59 years (n = 120) and those >60 years of age (n = 22) by enzyme‐linked ...
Inoka Sepali Aberathna, Achala Kamaladasa, Dinuka Guruge   +2 more
exaly   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

GUIDE TO UNDERSTANDING PSYCHIATRIC EFFECTS OF SINOPHARM VACCINE

Journal of Population Therapeutics and Clinical Pharmacology
Mahmood Riaz Mangi
openaire   +2 more sources

Fixed drug eruption after the Sinopharm COVID‐19 vaccine

JEADV Clinical Practice, 2022
AbstractAfter coronavirus disease 2019 (COVID‐19) became widespread around the world, several vaccines have been developed with variable efficacy and potency and based on different platforms to control the pandemic. One of these vaccines is Sinopharm (BBIBP‐CorV), which is an inactivated virus that was released by Sinopharm's Beijing institute in the ...
Guitti Pourdowlat, Ali Akbar Velayati, Parisa Honarpisheh   +2 more
exaly   +4 more sources

Complications and Efficacy of Sinopharm Vaccine among Liver and Kidney Transplantation

Current Drug Safety, 2023
Background: There are various vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, vaccination may lead to some complications. Objective: This study aimed to investigate the complications of transplant recipients who received the Sinopharm COVID-19 vaccine.
Rozita Khodashahi, Mohsen Aliakbarian, Mahin Ghorban Sabbagh, Kambiz Akhavan Rezayat, Mandana Khodashahi, Ebrahim Khaleghi, Maliheh Dadgar Moghaddam, Baran Razmkhah, Mahdi Nik Nazar, Nadia Sheikhi   +9 more
openaire   +2 more sources

Pulmonary Thromboembolism (PTE) after Sinopharm vaccination

2022
One of the serious side effects of COVID-19 vaccines is vaccine-induced immune thrombotic thrombocytopenia (VITT). A young man presented with pulmonary thromboembolism 7 days after receiving inactivated COVID-19 vaccine BIBP developed by Sinopharm/China.
Amin Hossienikia, Mohammadreza Tavakoli, Kaveh Same, Rasoul aliannejad, Zeinab Naderpour   +4 more
openaire   +1 more source

Adverse Effects Reported and Insights Following Sinopharm COVID-19 Vaccination

Current Microbiology, 2023
Vaccines are promising strategies for controlling COVID-19; however, COVID-19 vaccine side effects play a central role in public confidence in the vaccine and its uptake process. This study aimed to provide evidence on the post-vaccination early side effects of the BBIBP-CorV (Sinopharm) vaccine.
Alireza Mohebbi, Majid Eterafi, Nasrin Fouladi, Majid Golizadeh, Reza Panahizadeh, Shahram Habibzadeh, Kimia Karimi, Elham Safarzadeh   +7 more
openaire   +2 more sources

Scleromyxedema in an adult following Sinopharm BBIBP-CorV vaccination: An extremely rare phenomenon

Journal of Scleroderma and Related Disorders, 2022
Introduction: The Sinopharm BBIBP-CorV vaccine produces a variety of cutaneous adverse effects. Scleromyxedema is a mucinous connective tissue disorder that causes skin thickness and sclerodermoid changes. According to our findings, this is the first case of scleromyxedema induced by the Sinopharm immunization.
Amirhossein Parsaei, Somayeh Sadat Rezaei, Alireza Rahmani, Maryam Masoumi, Hojat Dehghanbanadaki, Somayyeh Norouzi, Mohammad Mehdi Riyahi, Reihane Tabaraii, Seyed Mohammad Hashem Montazeri   +8 more
openaire   +2 more sources

Coma Following the Sinopharm COVID-19 Vaccine: A Case Report

Biomedical Research Bulletin, 2023
The Chinese Sinopharm vaccine was produced in 2020 as an effective preventive measure against COVID-19. The low and non-serious adverse effects of the Sinopharm COVID-19 vaccine were reported in the literature. This report presents a 70-year-old man who underwent surgical burr-hole evacuation of the hematoma in the right and left parietal and frontal ...
Nazila Deznabi, Nasrin Abolhasanpour, Hanieh Salehi-Pourmehr   +2 more
openaire   +1 more source

Evaluation of anti-SARS-CoV-2 RBD antibody response after booster dose of SpikoGen® in individuals with two previous doses of Sinopharm and its association with HLA-DR and -DQ alleles.

Human Immunology
BACKGROUND It has been demonstrated that COVID-19 vaccines confer significant protection, but temporal decay in the vaccine-induced antibodies has been reported; therefore, a third booster dose was considered.
Amir Hossein Hajijafary, Somayeh Malekmohammad, A. Feizi, Peyman Bemani   +3 more
semanticscholar   +1 more source

A data-driven machine learning framework to predict side effects of AstraZeneca and sinopharm COVID-19 vaccines

Scientific Reports
Due to the widespread COVID-19 vaccinations, we are focusing more on side effects to immunizations that might affect people’s perceptions, and ultimately vaccine hesitancy.
Majid Eterafi, N. Fouladi, M. Amanzadeh, A. Mohammadnia, Elham Safarzadeh   +4 more
semanticscholar   +1 more source